Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Reprogramming of somatic cells to desired cell types holds great promise in regenerative medicine. However, production of transplantable hematopoietic stem cells (HSCs) in vitro by defined factors has not yet been achieved. Therefore, it is critical to fully understand the molecular mechanisms of HSC development in vivo. Here, we show that Fev, an ETS transcription factor, is a pivotal regulator of HSC development in vertebrates. In fev-deficient zebrafish embryos, the first definitive HSC population was compromised and fewer T cells were found in the thymus. Genetic and chemical analyses support a mechanism whereby Fev regulates HSC through direct regulation of ERK signaling. Blastula transplant assay demonstrates that Fev regulation of HSC development is cell autonomous. Experiments performed with purified cord blood show that fev is expressed and functions in primitive HSCs in humans, indicating its conserved role in higher vertebrates. Our data indicate that Fev-ERK signaling is essential for hemogenic endothelium-based HSC development.

Original publication

DOI

10.1182/blood-2012-10-462655

Type

Journal article

Journal

Blood

Publication Date

18/07/2013

Volume

122

Pages

367 - 375

Keywords

Animals, Aorta, Cell Lineage, DNA-Binding Proteins, Embryo, Nonmammalian, Endothelium, Extracellular Signal-Regulated MAP Kinases, Fetal Blood, Hematopoietic Stem Cells, Humans, MAP Kinase Signaling System, Nuclear Proteins, Transcription Factors, Zebrafish, Zebrafish Proteins